GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Pre-Mkt 08-06 05:23:53 EDT

51.46

-0.07

-0.14%

盘前52.01

+0.55+1.07%

05:21 EDT

High52.12	Low51.36	Vol2.48M
Open52.06	D1 Closing51.53	Amplitude1.47%
Mkt Cap104.09B	Tradable Cap100.19B	Total Shares2.02B
T/O128.23M	T/O Rate0.13%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":51.46,"timestamp":1785960000000,"preClose":51.53,"halted":0,"volume":2483314,"hourTrading":{"tag":"盘前","latestPrice":52.01,"preClose":51.46,"latestTime":"05:21 EDT","volume":2398,"amount":124824.779794,"timestamp":1786008099384,"change":0.55,"changeRate":0.010688,"amplitude":0.013214},"delay":0,"changeRate":-0.0013584319813700811,"floatShares":1946891708,"shares":2022697682,"eps":3.127128,"marketStatus":"Pre-Mkt","change":-0.07,"latestTime":"08-06 05:23:53 EDT","open":52.06,"high":52.12,"low":51.36,"amount":128228103.70632,"amplitude":0.014749,"askPrice":51.98,"askSize":1700,"bidPrice":51.94,"bidSize":1386,"shortable":3,"etf":0,"ttmEps":3.127128,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786023000000},"marketStatusCode":1,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":51.46,"dividendRate":0.035577,"preHourTrading":{"tag":"盘前","latestPrice":52.01,"preClose":51.46,"latestTime":"05:21 EDT","volume":2398,"amount":124824.779794,"timestamp":1786008099384,"change":0.55,"changeRate":0.010688,"amplitude":0.013214},"postHourTrading":{"tag":"盘后","latestPrice":51.51,"preClose":51.46,"latestTime":"19:34 EDT","volume":19188,"amount":987571.71,"timestamp":1785972846619,"change":0.05,"changeRate":0.000972,"amplitude":0.007773},"volumeRatio":0.48707282320056455,"impliedVol":0.299,"impliedVolPercentile":0.496},"requestUrl":"/m/hq/s/GSK/wiki","defaultTab":"wiki","newsList":[{"id":"2657529622","title":"GSK’s NEBULA-1 MASH Cirrhosis Trial: A New Catalyst in Metabolic Liver Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529622?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:31","pubTimestamp":1785947469,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The NEBULA-1 phase 3 study from GlaxoSmithKline aims to test efimosferm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-nebula-1-mash-cirrhosis-trial-a-new-catalyst-in-metabolic-liver-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-nebula-1-mash-cirrhosis-trial-a-new-catalyst-in-metabolic-liver-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","LU1829250122.USD","BK4532","BK4585","BK4007","GSKH","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552722","title":"GSK's New Drug Launches Will be Key to 2027 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552722","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656552722?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:38","pubTimestamp":1785854280,"startTime":"0","endTime":"0","summary":"1438 GMT - GSK's newly launched drugs will be key to reduce risk on the U.K. pharmaceutical company's outlook for next year, analysts at J.P. Morgan say. GSK recently launched blood-cancer drug Blenrep and asthma treatment Exdensur, while lung-cancer medicine Jideytro--which the company bought through its acquisition of Nuvalent--received U.S. approval last month. The trajectory of these products and others that are expected to reach the market next year like hepatitis B drug bepirovirsen and neladalkib--another lung-cancer drug from Nuvalent--will be increasingly focus for investors, the analysts say. The company's efforts to accelerate its strategy look encouraging but, with the next pivotal study results due to come only in 2028, potential risks to earnings in the near term might draw investors' attention, they add. Shares rise 0.2%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK's New Drug Launches Will be Key to 2027 Outlook","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","GSK","BK4588","BK4007","GSK.UK","GSKH","BK4585","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656855280","title":"Deutsche Bank  Keeps Their Hold Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656855280","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656855280?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:20","pubTimestamp":1785853221,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on GlaxoSmithKline today and set a price target of p2,000.00. Papadakis covers th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","DB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656535373","title":"GlaxoSmithKline (GSK) Receives a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2656535373","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656535373?lang=en_us&edition=fundamental","pubTime":"2026-08-04 15:57","pubTimestamp":1785830258,"startTime":"0","endTime":"0","summary":"In a report released today, James Gordon CFA from Barclays maintained a Sell rating on GlaxoSmithKline, with a price target of £19.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-sell-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-sell-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSKH","BK4532","GSK","GSK.UK","LU1829250122.USD","BK4585","BK4588","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656374583","title":"TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656374583","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656374583?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:16","pubTimestamp":1785763002,"startTime":"0","endTime":"0","summary":"In a report released today, Steve Scala from TD Cowen maintained a Hold rating on GlaxoSmithKline, with a price target of $70.00. According to TipR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","TD","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656050320","title":"Bernstein Sticks to Their Buy Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656050320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656050320?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:16","pubTimestamp":1785752188,"startTime":"0","endTime":"0","summary":"Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline today and set a price target of £30.10. Smith covers the Healthcare secto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-sticks-to-their-buy-rating-for-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-sticks-to-their-buy-rating-for-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655738850","title":"GSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2655738850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655738850?lang=en_us&edition=fundamental","pubTime":"2026-07-31 03:10","pubTimestamp":1785438626,"startTime":"0","endTime":"0","summary":"Deutsche Bank raised the firm’s price target on GSK (GSK) to 2,000 GBp from 1,950 GBp and keeps a Hold rating on the shares. Published first on The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-2000-gbp-from-1950-gbp-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-2000-gbp-from-1950-gbp-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804705","title":"GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804705?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:32","pubTimestamp":1785429167,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a Phase 1 trial called “A Phase 1, Observer-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-toddler-pneumococcal-booster-signaling-ongoing-vaccine-pipeline-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-toddler-pneumococcal-booster-signaling-ongoing-vaccine-pipeline-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK","BK4585","GSKH","BK4588","BBC","BK4007","GSK.UK","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655580480","title":"GSK Slips Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2655580480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655580480?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:09","pubTimestamp":1785427740,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  dropped 3.34% to GBP19.40 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index  falling 0.10% to 10,897.27.GSK PLC closed 14.99% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 6.0 million, compared to the 50-day average of 8.4 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655066588","title":"GSK Supply Chain President Registers Sale of Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2655066588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655066588?lang=en_us&edition=fundamental","pubTime":"2026-07-30 22:32","pubTimestamp":1785421948,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Regis Simard, the company’s President of Global Supply Chain, has sold 38,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-supply-chain-president-registers-sale-of-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-supply-chain-president-registers-sale-of-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GSK.UK","BK4585","GSK","LU1829250122.USD","BK4007","GSKH","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655894955","title":"GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2655894955","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655894955?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:27","pubTimestamp":1785338827,"startTime":"0","endTime":"0","summary":"GSK's  majority-owned ViiV Healthcare unit reported trial data that back Cabenuva's, also known as cabotegravir plus rilpivirine, potential as a long-acting injectable HIV treatment, according to a Wednesday statement.The LATA trial's week 96 results demonstrated Cabenuva's superiority over daily oral therapy in 476 virologically suppressed adolescents of ages 12 to 19 years with HIV in certain African countries, GSK said. Meanwhile, data from the US-based OPERA cohort showed that Cabenuva maintained virologic suppression comparable with daily oral therapy in 6,800 adults with HIV, GSK added.GSK also said six-month follow-up data from the phase 1 CLARITY trial supported a \"more favorable\" injection experience with long-acting cabotegravir, compared with lenacapavir, after a single dose.The company is also investigating an intramuscular formulation of cabotegravir dosed three times a year for HIV prevention, with data to be presented at a future medical event, according to the statement","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4007","BK4585","GSK.UK","XLV","LU0128526141.USD","GSKH","XBI","LU0029874061.USD","LU1829250122.USD","BK4532","HCSG","GSK","BK4137","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655997158","title":"Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2655997158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655997158?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:25","pubTimestamp":1785335147,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK with Shionogi as a shareholder, announced data to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cabenuva-demonstrates-superiority-to-daily-oral-therapy-in-adolescents-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cabenuva-demonstrates-superiority-to-daily-oral-therapy-in-adolescents-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","XLV","LU1829250122.USD","XBI","BK4585","BK4581","BK4588","BK4532","LABU","GSK","BK4007","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655653658","title":"GSK: Hold Rating Reaffirmed as Near-Term Strength Offsets Long-Term Uncertainties; 2,350p Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2655653658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655653658?lang=en_us&edition=fundamental","pubTime":"2026-07-29 17:36","pubTimestamp":1785317795,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sachin Jain from Bank of America Securities reiterated a Hold rating on GlaxoSmithKline, with a price target of p2,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gsk-hold-rating-reaffirmed-as-near-term-strength-offsets-long-term-uncertainties-2350p-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gsk-hold-rating-reaffirmed-as-near-term-strength-offsets-long-term-uncertainties-2350p-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816808","title":"GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816808","media":"Benzinga Earnings","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816808?lang=en_us&edition=fundamental","pubTime":"2026-07-29 01:30","pubTimestamp":1785259857,"startTime":"0","endTime":"0","summary":"GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its 2026 guidance.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/07/60737296/gsk-races-to-protect-profits-before-its-hiv-blockbuster-faces-generic-rivals","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSK.UK","BK4588","BK4585","GSK","BK4532","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886205","title":"GSK Rises Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886205","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886205?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:09","pubTimestamp":1785254940,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares advanced 3.47% to GBP20.29 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.83% to 10,871.02.GSK PLC closed 11.09% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 15.4 million, compared to the 50-day average of 8.0 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655888693","title":"GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2655888693","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655888693?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:54","pubTimestamp":1785254093,"startTime":"0","endTime":"0","summary":"GSK  licensor Hansoh's phase 3 trial of risvutatug rezetecan in osteosarcoma, the most common primary bone cancer, achieved its primary endpoint in progression-free survival, GSK said Tuesday.The trial, which was conducted in China in patients with osteosarcoma who have progressed or relapsed after receiving at least two prior lines of systemic therapy, showed that the therapy led to a statistically significant improvement in progression-free survival compared with chemotherapy, according to the statement.Hansoh also reported consistent benefit across secondary endpoints like overall survival, GSK added.Safety profile was consistent with previous findings in the same tumor type, with no new safety signals identified, the company said. Hansoh will use the trial data for regulatory submissions in China, GSK said.Price: 53.96, Change: +1.98, Percent Change: +3.80","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","BK4588","BK4585","GSKH","GSK.UK","BK4532","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654885957","title":"Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654885957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654885957?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:05","pubTimestamp":1785251131,"startTime":"0","endTime":"0","summary":"Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline today and set a price target of £28.25. Smith covers the Healthcare secto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-buy-rating-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-buy-rating-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654886478","title":"GSK Heading in Right Direction, but Investors Might Stay on Sidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2654886478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654886478?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:10","pubTimestamp":1785247800,"startTime":"0","endTime":"0","summary":"1410 GMT - GSK's research-and-development plan seems a step in the right direction, but investors might stay on the sidelines until the U.K. drugmaker is closer to its destination, Citi analysts say in a research note. The company unveiled plans to target annual cost savings of 1.9 billion pounds by 2029 to fund its drug pipeline and aid profitability. The plan involves a new R&D center in Cambridge, England, and a faster development path for seven drugs across 18 indications, doubling the number of late-stage studies due to start this year, Citi says. \"Overall the ambition is heading in the right direction but we think the market will wait for delivery,\" the analysts say. Shares jump 6%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSK.UK","ISBC","BK4588","BK4211","GSKH","BK4585","BK4007","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654000299","title":"GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2654000299","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654000299?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:55","pubTimestamp":1785246900,"startTime":"0","endTime":"0","summary":"GSK said it is launching a three-year program to cut costs and reinvest in its drug pipeline, seeking to protect profitability from the patent expiration of a key HIV drug later this decade.The U.K. d","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","GSKH","BK4585","BK4532","GSK","AAQC","BK4588","BK4007","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134029936","title":"Stock Track | GSK Soars 5.31% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Pipeline Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=1134029936","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134029936?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:35","pubTimestamp":1785245726,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline PLC (GSK) shares surged 5.31% in pre-market trading Tuesday, driven by a robust second-quarter earnings report that handily beat analyst expectations and promising pipeline news.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0331},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.019},{"period":"6month","weight":-0.1456},{"period":"1year","weight":0.3789},{"period":"ytd","weight":0.0493}],"compareEarnings":[{"period":"1week","weight":0.0553},{"period":"1month","weight":0.0246},{"period":"3month","weight":0.0522},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.2258},{"period":"ytd","weight":0.1289}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001243},{"month":3,"riseRate":0.608696,"avgChangeRate":0.019112},{"month":4,"riseRate":0.659574,"avgChangeRate":0.030828},{"month":5,"riseRate":0.404255,"avgChangeRate":-0.008644},{"month":6,"riseRate":0.595745,"avgChangeRate":0.010234},{"month":7,"riseRate":0.531915,"avgChangeRate":0.003565},{"month":8,"riseRate":0.574468,"avgChangeRate":0.005588},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}